聚乳酸-b-聚(N~ε-苄氧羰基-L-赖氨酸)-b-聚乙二醇的合成与表征

用端氨基聚乳酸做引发剂,在DMF中引发Nε-苄氧羰基-L-赖氨酸酐(Lys(Z)-NCA)聚合,合成了端氨基聚(Nε-苄氧羰基-L-赖氨酸)-b-聚乳酸两嵌段共聚物.以端羧基聚乙二醇经NHS活化与端氨基聚(Nε-苄氧羰基-L-赖氨酸)-b-聚乳酸偶联,合成了聚(乳酸-b-Nε-苄氧羰基-L-赖氨酸-b-乙二醇)三嵌段聚合物.利用IR、1H-NMR、GPC和TEM对它们的结构、形态进行了表征,结果表明,所合成的分子量可控、分子量分布窄(Mw/Mn=1.07)的嵌段共聚物,酰化反应产率达70%以上.同时聚乙二醇和Nε-苄氧羰基-L-赖氨酸被引入到聚乳酸主链中,在聚合物侧链脱保护后有望改善聚乳酸的细胞亲和性。     

PCL-PEG-PCL嵌段共聚物的合成与性能

研究了氮气保护下，以辛酸亚锡和聚乙二醇为共引发剂，引发ε－己内酯的开环聚合反应。在聚乙二醇（PEG）链段分子量保持不变的情况下，全盛了不同分子量聚己丙酯链段的PCL－PEG－PCL三嵌段共聚物，以及不同分子量PEG链段而聚己内酯链段相同的嵌段共聚物。采用GPC、DSC、FTIR、^1H-NMR及吸水性测试等分析手段表征了共聚物的结构和性能。结果表明聚合反应为可控反应，可通过调整聚乙二醇与ε－己内酯的比例来控制聚合物的分子量；聚乙二醇组分的引入有效地改善了聚合物的亲水性，并破坏了其结晶性。     

超临界CO2中苯乙烯RAFT分散聚合

以末端带有三硫代碳酸酯的聚二甲基硅氧烷(PDMS-TTC)为大分子链转移剂,在超临界CO2中通过苯乙烯的可逆加成-断裂链转移(RAFT)聚合制备了聚二甲基硅氧烷-b-聚苯乙烯(PDMS-b-PS)嵌段共聚物,对聚合反应动力学以及产物的组成、分子量和形貌等进行了表征.由于PDMS链段可溶于超临界CO2而PS链段不溶,因此在超临界CO2中制备PDMS-b-PS嵌段共聚物的过程是以嵌段共聚物自身作为分散稳定剂的RAFT分散聚合,产物为粒径较均一的球形颗粒.     

聚谷氨酸苄酯-聚乙二醇嵌段共聚物的合成和表征

通过嵌段共聚技术,合成了聚γ－苄基L－谷氨酸（PBLG）作为疏水性链段－聚乙二醇（PEG）作为亲水性链段的嵌段共聚物。用对甲苯磺酸酯化－氨水皂化法合成带有端氨基的聚乙二醇（AT－PEG）,光气－甲苯液相法制备谷氨酸苄酯－N－羟酸酐（BLG－NCA）。用AT－PEG引发BLG－NCA聚合制备PBLG－PEG或PBLG－PEG－PBLG,通过不同的单体、引发剂浓度比调节聚合物分子量。用GPC、^1HNMR、IR对聚合物的结构进行了表征。结果表明,带有端氨基的聚乙二醇确实能引发BLG－NCA生成PBLG和PEG的嵌段共聚物,产物中几乎没有残存的PEG,共聚物的分子量可控。     

聚乙二醇-聚乳酸-聚甲基丙烯酸羟乙酯两亲性三嵌段聚合物的合成及其自组装研究

具有生物相容性的两亲性嵌段共聚物在水中易形成胶束,在医学诊断、体内药物缓释及药物靶向输送方面具有广阔的应用前景.利用二嵌段聚合物聚乙二醇-聚乳酸(PEG-PLA)引发甲基丙烯酸羟乙酯的原子转移自由基聚合,制备了两亲性三嵌段聚合物聚乙二醇-聚乳酸-聚甲基丙烯酸羟乙酯(PEG-PLA-PHEMA),利用凝胶渗透色谱(GPC),红外光谱(FT-IR),1H NMR表征了其聚合物组成;然后利用透析法制备了不同分子量的聚合物胶束,动态光散射(DLS)和透射电镜(TEM)结果表明其形貌规整、尺寸均一,而且胶束粒径在PEG和PLA链段长度不变的条件下,随PHEMA链段的变长而增大.PHEMA链上大量羟基的存在为聚合物胶束的功能化改性提供了反应位点,加上本身完全由具良好生物相容性的聚合物制备,使其在可控药物释放方面具有很大的应用潜力.     

选择性催化混合单体制备多组分聚酯的研究进展

以聚乳酸和聚碳酸酯等为代表的生物可降解高分子材料已被应用于包装材料和生物医用等领域.然而受链段结构的影响,这类均聚物材料在实际应用中受到了一定限制.将不同性质聚合物链段通过共价键连接形成的嵌段共聚物具有组分均匀、性能可控等优点,是优化材料性能的一种方法.本文概述了环酯、环氧化物和CO2(或环状酸酐)的多元共聚反应合成嵌...     

聚乙二醇-聚乳酸共聚物胶束溶液的冷冻干燥及胶束体外释药动力学研究

合成了一系列亲水、疏水链段质量比例不同的聚乙二醇-聚乳酸(PEG-PLA)嵌段共聚物胶束, 并以两性霉素B为模型药物制备了载药胶束. 为获得稳定性良好的、可长期储存的载药胶束剂型, 对胶束进行了冷冻干燥. 使用不同浓度的糖类(包括甘露糖、海藻糖、葡萄糖)、泊洛沙姆188 (Pluronic F68)、聚乙二醇作为冻干保护剂, 以冻干产品的重分散性、冻干前后胶束的粒径及多分散性为指标评价各种保护剂的保护效果. 结果发现, 当嵌段聚合物中聚乳酸链段的质量百分比小于或等于聚乙二醇时, 糖类、Pluronic F68和PEG均可以起到有效的冻干保护作用; 而对于聚乳酸链段质量比例较大的共聚物胶束, 只有PEG和Pluronic F68能够起到较好的冻干保护作用. 对载药胶束体外释放研究表明, 聚合物胶束的体外释放缓慢, 符合一级动力学特征.     

三臂支化PLLA-PDLA嵌段共聚物的合成及立构复合结晶行为

以三羟甲基乙烷为起始剂, 开环聚合L-丙交酯(LLA), 合成三臂支化左旋聚乳酸(PLLA)预聚物. 采用端基活化技术对预聚物进行端羟基活化, 再与D-丙交酯(DLA)进行开环聚合, 合成了不同分子量的三臂支化左旋聚乳酸-右旋聚乳酸(PLLA-PDLA)嵌段共聚物. 采用核磁共振谱和凝胶渗透色谱等对样品的结构和分子量进行测试, 结果表明,合成的嵌段共聚物链结构具有链段立构规整度和高分子量的特点; 通过调节DLA单体与PLLA预聚物的投料比, 可实现对PLLA-PDLA嵌段共聚物的序列结构调控. 差示扫描量热仪和广角X 射线衍射结果表明, 三臂支化PLLA-PDLA嵌段共聚物的异构体分子间生成立构复合晶体, 其熔点高于200℃; 共聚物的嵌段序列结构对材料的凝聚态转变行为有很大的影响.     

两亲性树枝状嵌段共聚物刷的合成与构象研究

近期研究发现两亲性嵌段共聚物刷能引发“有序自发乳化”,一步法制备有序多孔光晶微球.上述研究主要基于侧链为线形聚合物的嵌段共聚物刷,而侧链拓扑结构变化对乳液受限自组装的影响尚不明确.本工作中设计合成了亲水和疏水的降冰片烯基楔形单体,并通过顺序开环易位聚合(ROMP)成功合成了一类两亲性树枝状嵌段共聚物刷.通过核磁氢谱(¹H-NMR)清晰表征了产物的化学结构,凝胶渗透色谱(GPC)表明共聚物的分子量呈较窄的单峰分布,聚合反应过程具有较好的可控性.通过改变单体和催化剂的比例获得不同分子量的共聚物刷,利用凝胶渗透色谱联用光散射(GPC-MALS)研究了侧链结构对聚合物溶液构象的影响,结果显示一代树枝状共聚物刷表现为无规线团构象,而二代产物则呈现棒状构象,单个聚合物链的原子力(AFM)表征证实了上述结果.     

用固体高分辨NMR研究聚(L-丙氨酸)-聚乙二醇单甲醚双嵌段共聚物的微相结构与链段运动

利用固体高分辨¹³CCP/MAS及二维WISE核磁共振技术研究了聚(L-丙氨酸)-聚乙二醇单甲醚双嵌段共聚物(MPEG-b-PLA)在固态下的微相结构和链段运动行为.结果表明,聚乙二醇链段在形成嵌段共聚物后结晶度明显下降,同时存在晶区和非晶区,从而表现出两种不同的运动状态.而聚乙二醇链段的引入对聚L-丙氨酸链段影响不大,嵌段共聚物中聚L-丙氨酸链段高度结晶,同时含有大量的α螺旋结构,分子链运动严重受限,估计聚L-丙氨酸链段的相区尺寸很小.     

生物可降解5-氟尿嘧啶载药微球的制备及性能研究

5-氟尿嘧啶(5-Fu)为水溶性嘧啶类抗代谢药,是治疗实体肿瘤的首选药物．但5-Fu毒性很大,血浆中停留半衰期t1／2仅为10～20min．为了减少氟尿嘧啶的毒副作用并提高药物利用率,可以将其制成聚合物载药微球．聚酯类高分子是较为常用的生物降解型药物载体材料,其中聚乳酸(PLA)及其共聚物具有良好的生物相容性及生物可降解性,常被广泛应用于药物缓释材料,     

Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection

The leading principle of non-viral delivery systems for gene therapy is to mediate high levels of gene expression with low cytotoxicity. Nowadays, biodegradable nanoparticles formulated with poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) were wildly developed. However, the relative lower gene transfection efficiency and higher cytotoxicity still remained critical problems. To address these limitations, PLA-PEG nanoparticles have been composited with other components in their formulation. Here, a novel cationic lipid, 6-lauroxyhexyl lysinate (LHLN), was fabricated onto PLA-PEG nanoparticles as a charge modifier to improve the transfection efficiency and cytotoxicity. The obtained cationic LHLN modified PLA-PEG nanoparticles (LHLN-PLA-PEG NPs) could condense pDNA thoroughly via electrostatic force, leading to the formation of the LHLN-PLA-PEG NPs/pDNA complexes (NPs/DNA complexes). The nanoparticles obtained have been characterized in relation to their physicochemical and biological properties, and the results are extremely promising in terms of low cell toxicity and high transfection efficiency. These results indicated that the novel cationic LHLN modified PLA-PEG nanoparticles could enhance gene transfection in vitro and hold the potential to be a promising non-viral nanodevice.     

Preparation and Characterization of Poly(D,L-Lactide) (PLA) and Poly(D,L-Lactide)-Poly(Ethylene Glycol) (PLA-PEG) Nanocapsules Containing Antitumoral Agent Methotrexate

Summary: The aims of the present work were to prepare and characterize nanocapsules containing antitumoral agent methotrexate (MTX) from poly(D ,L -lactide) (PLA) and poly(D ,L -lactide)-poly(ethylene glycol) diblock copolymer (PLA-PEG) with the purpose of administrating this drug by topical ocular route for primary ocular lymphoma treatment. Nanocapsules were prepared by the interfacial deposition of preformed polymer. The influences of the initial amount of MTX on the encapsulation efficiency, drug recovery and drug content, as well as the physicochemical properties of the particles were evaluated. The particle mean diameters were 246 and 146 nm, and zeta potential values were −38.8 and −33.6 mV, for the MTX-loaded nanocapsules prepared from PLA and PLA-PEG, respectively. The methotrexate content in the particles increased with the increasing in the drug amount added to the formulations, but the drug recovery decreased significantly. After 4 h of in vitro release, 28 and 86% of MTX was released from PLA and PLA-PEG nanocapsules, respectively.     

聚羧酸类超塑化剂分子结构对石膏分散性能的影响

研究了甲基丙烯酸-甲氧基聚乙二醇甲基丙烯酸酯(MAA-MPEGMA)、甲基丙烯酸-烯丙基聚乙二醇醚(MAA-APEG)、丙烯酸-烯丙基聚乙二醇醚(AA-APEG)三类梳形聚羧酸类接枝共聚物以及丙烯酸均聚物(PAA)对石膏粉体分散性能和凝结时间的影响.聚合物侧链长度越短、分子量越小、电荷密度越高对石膏的分散性能越好,同时...     

聚谷氨酸接枝聚乙二醇@碳酸钙遮蔽体系用于提高聚乙烯亚胺基因转染效率

设计并合成了聚谷氨酸-聚乙二醇@碳酸钙(PPG@CaCO₃)纳米遮蔽体系,用于遮蔽聚乙烯亚胺(PEI)。一方面,聚谷氨酸-聚乙二醇(PPG)可以降低PEI引起的细胞毒性,更有利于体内应用;另一方面,CaCO₃可有效改善PPG导致的转染效率下降,并在一定程度上提高PEI的细胞转染效率。对比遮蔽体系PPG@CaCO₃和聚谷氨酸-聚乙二醇@磷酸钙[PPG@Ca₃(PO₄)₂]发现,PPG@CaCO₃在微酸性环境中释放二氧化碳气体是提高细胞转染效率的关键因素。小鼠体内循环实验表明,PPG@CaCO₃遮蔽体系可以增加载体在血液中的循环时间。因此,PPG@CaCO₃遮蔽体系对于改善阳离子类基因载体的体内应用起到重要作用。     

Preparation and Electrochemical Behaviors of AA-PEGMA Copolymer Film Electrode

A new kind of comblike copolymer film composed of acrylic acid-polyethylene glycol monomethyl ether acrylate copolymer(AA-PEGMA copolymer) was successfully synthesized to immobilize hemoglobin(Hb). FTIR, UV-Vis and CD spectra suggest that Hb kept its original structure in the AA-PEGMA copolymer film without denaturation. A pair of well-defined, quasi-reversible cyclic voltammetric peaks at around –270 mV vs. saturated calomel electrode(SCE) for the Hb Fe(Ⅲ)/Fe(Ⅱ) redox couple was observed on the film-modified electrode in phosphate buffer solution(PBS, pH=7.0). The formal potential of Hb/AA-PEGMA copolymer film-modified electrode is linearly dependent on solution pH with a slope of –46.3 mV/pH, illustrating that one-proton transfer was accompanied with each electron transfer. Furthermore, the modified electrode displayed electrocatalytic response to the reduction of H₂O₂ with a linear range of 3.5―126 μmol/L and a detection limit of 1.17 μmol/L. In conclusion, the AA-PEGMA copolymer film was proved to be an excellent matrix for the immobilization and electrochemistry of proteins.     

星形PLA-PEG嵌段共聚物胶束的制备与表征

以胆酸为引发剂,用辛酸亚锡催化丙交酯开环聚合合成星型CA-PLA。利用DCC为脱水剂,将不同分子量的端羧基化PEG与星型CA-PLA偶联,合成一系列以胆酸为核的星形两亲性嵌段共聚物,用透析法制备共聚物胶束,并用TEM和DLS研究胶束的性质。合成了分子量为6000和12000的两种CA-PLA,其分子量可以通过胆酸羟基与丙交酯的比例进行控制。将分子量2000和5000的PEG分别与两种CA-PLA偶联,合成了四种星型CA-PLA-PEG嵌段共聚物。共聚物胶束形貌为均匀的球形,粒径为20-40nm,且随共聚物中PLA链段分子量的增加而增大,随PEG链段分子量的增加而减小。临界胶束浓度(CMC)低于同等链段长度的线型PLA-PEG嵌段共聚物胶束。     

B2O3 reinforced polylactic acid/thermoplastic polyethylene glycol shape memory composites

Recently, there has been a great demand for boron-containing compounds (BCCs) with unique biological properties. The demand for the use of these compounds not alone but as additives in composite materials is increasing day by day. In this study, the effect of adding B₂O₃ compound to the blend of PLA and PEG polymers, which is an important biocompatible shape memory polymer, was investigated. In order to examine the effect of increasing B₂O₃ additive on the thermal properties of PLA-PEG blend, it was determined by using a Differential Scanning Calorimetry (DSC) and thermogravimetric analyzer (TGA), and it was seen that while the melting temperature of PEG decreased, the melting temperature of PLA increased. In addition, when the thermal stability of the composites was examined, increasing of thermal stability was observed with the addition of B₂O₃ and a three-step degradation occurred. It was determined that the B₂O₃/PLA-PEG composite was homogeneous by taking X-ray measurements and SEM measurements. The antimicrobial property of the PLA-PEG blend improved with the increasing B₂O₃ contribution were observed from the antimicrobial activity measurements of the composite against 4 different bacteria. However, it was determined that the PLA-PEG blend preserved its shape memory effect with increasing diboron trioxide contribution.     

Size effect on competition of two diffusion mechanisms for drug molecules in amorphous polymers

Diffusion of drug molecules in polymer materials is of great importance in controlled drug release, and the investigation of the mechanism of drug release from the polymer matrix would help us to understand the release behavior of the controlled release system. In this work, molecular dynamics simulations were employed to investigate the diffusion mechanisms of penetrant molecules with different sizes in poly(lactic acid-co-ethylene glycol) (PLA-PEG). The size effect on the diffusion mechanism of penetrant molecules in polymer matrixes was discussed in detail. A competition mechanism in a two-step diffusion process-(1) motion within the cavities (free volumes), and (2) jumps between cavities or movement of the cavity itself originated from the wriggling of the polymer chains-was observed, and the contributions of these two factors to the diffusion coefficient were successfully separated. With the medium volume of penetrant molecules (e.g., benzene), a competition between these two steps was observed. Step (2) controlled the diffusion when penetrant molecules became bigger.     

Bulk modification of PDMS microchips by an amphiphilic copolymer

A simple and rapid bulk-modification method based on adding an amphiphilic copolymer during the fabrication process was employed to modify PDMS microchips. Poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) was used as the additive substance. Compared to the native PDMS microchips, both the contact angle and the EOF of the bulk-modified PDMS microchips decreased. The effects of the additive loading and the pH on the EOF were investigated in detail. The bulk-modified PDMS microchips exhibited reproducible and stable EOF behavior. The application of the bulk-modified PDMS microchips was also studied and the results indicated that they could be successfully used to separate amino acids and to suppress protein adsorption.